Ads
related to: clindamycin dose for cellulitis days in children under 6- Safety & Side Effect Info
Learn About The Side Effects
For This Management Option
- Understanding PROS
PIK3CA-Related Overgrowth Spectrum.
Learn About PROS-Related Conditions
- Patient Support Program
Find Resources For Navigating PROS.
Discover Helpful Patient Resources
- Financial Resources
Find Co-Pay Information
See If You Are Eligible For Savings
- Safety & Side Effect Info
Search results
Results From The WOW.Com Content Network
Perianal cellulitis, also known as perianitis or perianal streptococcal dermatitis, is a bacterial infection affecting the lower layers of the skin around the anus. [1] [2] [3] It presents as bright redness in the skin and can be accompanied by pain, difficulty defecating, itching, and bleeding.
Clindamycin is a lincosamide antibiotic medication used for the treatment of a number of bacterial infections, including osteomyelitis (bone) or joint infections, pelvic inflammatory disease, strep throat, pneumonia, acute otitis media (middle ear infections), and endocarditis. [5]
Penicillin G, 5 million units IV initial dose, then 3 million units every 4 hours until delivery or ampicillin, 2 g IV initial dose, then 1 g IV every 4 hours until delivery. [4] [12] [14] Appropriate IAP in GBS colonized women should start as soon as possible once labour starts or the waters have broken. When the first dose is given at least 4 ...
For premium support please call: 800-290-4726 more ways to reach us
Clindamycin should be given in conjunction with quinine as a 300 mg dose (in adults) four times a day for five days. The only side effects recorded in patients taking clindamycin are nausea, vomiting and abdominal pains and cramps.
[30] [31] Intravenous vancomycin is recommended for IAP in women colonized with a clindamycin-resistant Group B Streptococcus strain and a severe penicillin allergy. [ 29 ] [ 31 ] There are two ways to identify female candidates to receive intrapartum antibiotic prophylaxis: a risk-based approach or a culture-based screening approach.